7681. Depression and post-traumatic stress during major social unrest in Hong Kong: a 10-year prospective cohort study.
作者: Michael Y Ni.;Xiaoxin I Yao.;Kathy S M Leung.;Cynthia Yau.;Candi M C Leung.;Phyllis Lun.;Francis P Flores.;Wing Chung Chang.;Benjamin J Cowling.;Gabriel M Leung.
来源: Lancet. 2020年395卷10220期273-284页
Hong Kong has been embroiled in increasingly violent social unrest since June, 2019. We examined the associated population mental health burden, risk factors, and health-care needs.
7684. Adhesion-related readmissions after open and laparoscopic surgery: a retrospective cohort study (SCAR update).
作者: Pepijn Krielen.;Martijn W J Stommel.;Pille Pargmae.;Nicole D Bouvy.;Erica A Bakkum.;Harold Ellis.;Michael C Parker.;Ewen A Griffiths.;Harry van Goor.;Richard P G Ten Broek.
来源: Lancet. 2020年395卷10217期33-41页
Adhesions are the most common driver of long-term morbidity after abdominal surgery. Although laparoscopy can reduce adhesion formation, the effect of minimally invasive surgery on long-term adhesion-related morbidity remains unknown. We aimed to assess the impact of laparoscopy on adhesion-related readmissions in a population-based cohort.
7700. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial.
作者: Niels R Holm.;Timo Mäkikallio.;M Mitchell Lindsay.;Mark S Spence.;Andrejs Erglis.;Ian B A Menown.;Thor Trovik.;Thomas Kellerth.;Gintaras Kalinauskas.;Lone Juul Hune Mogensen.;Per H Nielsen.;Matti Niemelä.;Jens F Lassen.;Keith Oldroyd.;Geoffrey Berg.;Peteris Stradins.;Simon J Walsh.;Alastair N J Graham.;Petter C Endresen.;Ole Fröbert.;Uday Trivedi.;Vesa Anttila.;David Hildick-Smith.;Leif Thuesen.;Evald H Christiansen.; .
来源: Lancet. 2020年395卷10219期191-199页
Percutaneous coronary intervention (PCI) is increasingly used in revascularisation of patients with left main coronary artery disease in place of the standard treatment, coronary artery bypass grafting (CABG). The NOBLE trial aimed to evaluate whether PCI was non-inferior to CABG in the treatment of left main coronary artery disease and reported outcomes after a median follow-up of 3·1 years. We now report updated 5-year outcomes of the trial.
|